Earnings

Bristol-Myers Squibb Q3 Adj. EPS $1.35 Beats $1.17 Estimate, Sales $13.069B Beat $12.738B Estimate

Oct 29, 2026 · 06:59 AM ET· updated 46m ago

Bristol-Myers Squibb (NYSE:BMY) reported quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $1.17 by 15.38 percent. This is a 17.18 percent decrease over earnings of $1.63 per share from

Why It Matters

Bristol-Myers Squibb made more money per share than experts predicted this quarter. When a company beats expectations, it shows strong management and healthy business operations.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

BMY61.50

+0.93 (+1.54%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.